Exploring Chondrocyte Integrin Regulation of Growth Factor IGF-I Expression from a Transient pAAV Vector

dc.contributor.advisorTrippel, Stephen B.
dc.contributor.authorRatley, Samantha Kay
dc.contributor.otherLin, Chien-Chi
dc.contributor.otherStocum, David L.
dc.date.accessioned2013-08-20T19:44:29Z
dc.date.available2013-08-20T19:44:29Z
dc.date.issued2013-08-20
dc.degree.date2012en_US
dc.degree.disciplineDepartment of Biomedical Engineeringen_US
dc.degree.grantorPurdue Universityen_US
dc.degree.levelM.S.en_US
dc.descriptionIndiana University-Purdue University Indianapolis (IUPUI)en_US
dc.description.abstractInsulin-like Growth Factor I (IGF-I) is a growth factor that stimulates both mitogenic and anabolic responses in articular chondrocytes. While it has been shown that exogenous IGF-I can regulate chondrocyte integrins, little is known regarding regulatory effects of IGF-I produced from a transiently expressed plasmid based adeno-associated virus (pAAV) vector. Because chondrocytes are using cellular machinery to overexpress IGF-I, it is of interest to see whether or not pAAV IGF-I will significantly upregulate or downregulate chondrocyte integrins. Additionally, it is of interest to know whether chondrocyte adhesion through integrins will have any regulatory effects on the production of IGF-I from the transgene. Therefore, this study will ascertain if pAAV IGF-I will have similar effects that exogenous IGF-I has on integrin regulation and if integrin silencing mechanisms will affect the production of IGF-I from the transgene. To test these hypotheses, adult articular chondrocytes were doubly transfected with the pAAV vector for IGF-I and short interference ribonucleic acid (siRNA) for integrins beta 1 and alpha V. Gene products were monitored at the transcriptional levels using quantitative real time polymerase chain reactions (qPCR) and IGF-I protein production was monitored at the translational level using enzyme linked immunoabsorbant assays (ELISAs). Adult articular chondrocytes doubly transfected were encapsulated in a three dimensional hydrogel system to simulate an in vivo environment. Samples were collected for analysis at days 2, 4, and 6 post encapsulation. Results show that IGF-I treatment with the pAAV vector does not cause significant changes in the transcriptional regulation of the beta 1 integrin in a three dimensional hydrogel system. The pAAV IGF-I vector did not cause significant regulatory changes on integrin alpha V at any time point during the experiment. Additionally, by knocking down the expression levels of integrins by using siRNA, it was shown that integrin knockdown does not have a significant regulatory effect on transcriptional or translational expression levels of IGF-I from the pAAV vector.en_US
dc.embargoindefinitelyen_US
dc.identifier.urihttps://hdl.handle.net/1805/3444
dc.identifier.urihttp://dx.doi.org/10.7912/C2/1333
dc.language.isoen_USen_US
dc.subjectBiomedical Engineeringen_US
dc.subjectGene Therapyen_US
dc.subjectTissue Engineeringen_US
dc.subjectRegenerative Medicine and Biologyen_US
dc.subjectArticular Cartilage Repairen_US
dc.subjectIntegrinsen_US
dc.subjectGrowth Factorsen_US
dc.subjectInsulin-like Growth Factor Ien_US
dc.subjectsiRNAen_US
dc.subjectRGD Peptidesen_US
dc.subjectChondrocytesen_US
dc.subject.lcshBiomedical engineeringen_US
dc.subject.lcshGene therapyen_US
dc.subject.lcshTissue engineeringen_US
dc.subject.lcshRegenerative medicineen_US
dc.subject.lcshGrowth factors -- Biotechnologyen_US
dc.subject.lcshIntegrinsen_US
dc.subject.lcshPeptides -- Biotechnologyen_US
dc.subject.lcshCartilage cellsen_US
dc.subject.lcshGenetic transcription -- Regulationen_US
dc.titleExploring Chondrocyte Integrin Regulation of Growth Factor IGF-I Expression from a Transient pAAV Vectoren_US
dc.typeThesis
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Ratley_thesis_Final.pdf
Size:
1.64 MB
Format:
Adobe Portable Document Format
Description:
August 2012 Thesis - Samantha Ratley
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: